Zurich Cantonal Bank
RIGL icon

Zurich Cantonal Bank’s Rigel Pharmaceuticals RIGL Stock Holding History

Zurich Cantonal Bank’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-429
Closed -$18.4K – 3320
2025
Q4 		$18.4K Buy
+429
New +$16.2K ﹤0.01% 2468

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zurich Cantonal Bank's RIGL Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Rigel Pharmaceuticals (RIGL) in Q1 2026: 335 shares worth $9.06K. The stake represents ﹤0.01% of the portfolio and ranks #2485 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in RIGL as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in RIGL in Q2 2018 and has held it in 22 quarters since. The position peaked at $189K in Q2 2021. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • Zurich Cantonal Bank held 335 shares of Rigel Pharmaceuticals worth $9.06K as of Q1 2026.
  • Rigel Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Rigel Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2485 holding.
  • Zurich Cantonal Bank first reported a position in Rigel Pharmaceuticals in Q2 2018 and has held it in 22 quarters since.
  • Zurich Cantonal Bank's Rigel Pharmaceuticals position peaked at $189K in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.